ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
22 announcements with these filters
NGL Fine Chem received a GST Show Cause Notice for FY 2022-23 with a total demand of ₹6.19 Crore. The company intends to contest the notice.
NGL Fine-Chem Limited has commenced commercial production at Phase II of its Greenfield facility in Tarapur. The total investment for the expansion facility is approximately ₹222 Crore.
NGL Fine-Chem Limited held its 45th Annual General Meeting on August 25, 2026. The meeting transacted several ordinary and special business items as listed in the Notice.
NGL Fine-Chem Limited issued a corrigendum to its FY 2025-26 Annual Report. The correction clarifies that CSR amounts were incorrectly reported in Crores instead of Lakhs.
NGL Fine-Chem reported robust Q1FY27 performance with Revenue of ₹139.16 Cr (up 33.6% YoY) and PAT of ₹18.40 Cr (up 99.1% YoY). Growth was driven by sustained demand and forex gains.
NGL Fine-Chem paid fines totalling Rs. 23,600 to NSE and BSE for delayed board meeting intimation. The Board has strengthened internal compliance mechanisms.
NGL Fine - Chem Ltd reported revenue from operations of ₹139.2 Cr (+33.6% YoY) and net profit of ₹18.4 Cr (+100.0% YoY) for Q1 FY27.
The board approved standalone and consolidated unaudited financial results for the quarter ended June 30, 2026, and noted the statutory auditor's limited review reports.
NGL Fine-Chem Ltd has scheduled a board meeting on August 12, 2026, to consider and approve the unaudited standalone and consolidated financial results.
NGL Fine-Chem Limited issued notice for its 45th Annual General Meeting on August 25, 2026. Agenda items include financial statements, dividends, and director appointments.
NGL Fine-Chem Limited has submitted its Business Responsibility and Sustainability Report for the financial year 2025-26 in compliance with SEBI LODR regulations.
NGL Fine-Chem Limited submitted the Notice of its 45th Annual General Meeting and the Annual Report for the financial year 2025-26.
NGL Fine Chem Ltd filed its quarterly shareholding pattern for the period ending June 30, 2026. The filing details holdings across promoter and public categories.
NGL Fine-Chem reported strong Q4 FY26 results with 57% YoY revenue growth and significant margin expansion. Management focuses on capacity expansion and penetrating regulated markets (Europe/US).
NGL Fine-Chem submitted its Annual Secretarial Compliance Report for FY 2025-26. The report highlights a procedural disclosure delay regarding a director's retirement while confirming overall compliance.
NGL Fine Chem reports a strong recovery in FY26, driven by higher volumes and expanded intermediate production. However, management remains cautious about returning to peak historical margins due to persistent global competition and cost pressures.
NGL Fine-Chem delivered strong FY26 performance with revenue up 36% to ₹501cr and PAT up 127% to ₹48cr, driven by volume growth in the animal health segment.
NGL Fine-Chem re-appointed Mr. Rajesh Lawande and Mrs. Sarala Menon for five-year terms. The board also appointed new internal and cost auditors for the next year.
NGL Fine-Chem recommended a final dividend of ₹1.75 per equity share for 2026. The record date is August 18, with payment scheduled by September 23.
NGL Fine - Chem Ltd reported revenue from operations of ₹149.2 Cr (+57.1% YoY) and net profit of ₹13.5 Cr (+2600.0% YoY) for Q4 FY26.
NGL Fine-Chem approved its FY2026 financial results and recommended a Rs.1.75 per share final dividend. Consolidated annual revenue reached ₹500.95 Crore with ₹48.13 Crore net profit.
NGL Fine-Chem Limited scheduled a board meeting for May 21, 2026. The board will consider and approve audited standalone and consolidated annual financial results.